REGULUS THERAPEUTICS INC.

Analyst Reco. Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-03 EDT			5-day change	1st Jan Change
2.65 ^USD	-1.49%		+9.50%	+107.03%

03-21	Regulus Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-21	Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Canaccord Genuity Trims Price Target on Regulus Therapeutics to $11 From $12, Maintains Buy Rating	03-19	MT
Leerink Partners Initiates Regulus Therapeutics at Outperform Rating With $6 Price Target	03-18	MT
Wells Fargo Adjusts Regulus Therapeutics Price Target to $3 From $2, Maintains Equal Weight Rating	03-13	MT
Canaccord Genuity Raises Regulus Therapeutics' Price Target to $12 From $9, Keeps Buy Rating	23-09-21	MT
HC Wainwright Adjusts Price Target on Regulus Therapeutics to $9 From $20, Maintains Buy Rating	23-04-21	MT
Canaccord Genuity Starts Regulus Therapeutics at Buy With $9 Price Target	22-11-08	MT
Wedbush Adjusts Regulus Therapeutics' Price Target to $0.42 From $1 Following Private Equity Placement; Neutral Rating Kept	22-01-21	MT
REGULUS THERAPEUTICS : Cantor Fitzgerald Reinstates Regulus Therapeutics at Overweight with $2 Price Target	21-09-02	MT
REGULUS THERAPEUTICS : Wedbush Halves Regulus Therapeutics' PT to $1 From $2 on RGLD4326 Timeline for Autosomal Dominant Polycystic Kidney Disease; Neutral Rating Kept	21-05-14	MT
REGULUS THERAPEUTICS : HC Wainwright Adjusts Regulus Therapeutics' Price Target to $2 From $1.50, Maintains Buy Rating	21-05-14	MT
REGULUS THERAPEUTICS : Wedbush Adjusts Price Target on Regulus Therapeutics to $2 From $1, Maintains Neutral Rating	21-02-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer